Social Anxiety and Avoidance in Head and Neck Cancer Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- Level of social anxiety and avoidance in HNC patients post-treatment
研究概览
简要总结
RATIONALE: Patients who undergo treatment for head and neck cancer may become anxious and avoid contact with other people. Learning how cancer treatment may cause anxiety in patients with head and neck cancer may help improve the quality of life in these patients.
PURPOSE: This clinical trial is studying anxiety and avoidance of others in patients previously treated for head and neck cancer.
详细描述
OBJECTIVES:
- Determine the relationship between treatment-provoked social anxiety and avoidance in patients previously treated for head and neck cancer.
- Determine the relationship between pre-cancer psychiatric diagnosis and post-treatment social anxiety and avoidance in these patients.
- Determine the effect of social anxiety and/or avoidance on the quality of life of these patients.
- Investigate the specificity of these relationships in patients with head and neck cancer by comparing patients with head and neck cancer to patients with lung cancer.
OUTLINE: This is a cross-sectional study. Patients are stratified according to prior treatment type (significantly impairing [surgery] vs less impairing [chemotherapy/radiotherapy]).
Patients undergo a face-to-face interview with a mental health clinician over 2 hours. Patients complete multiple psychiatric/psychological assessments during the interview, including the Structured Clinical Interview for DSM-IV (SCID); the Liebowitz Social Anxiety Scale (SAS); the Performance Status Scale for Head and Neck Cancer Patients (PSS-HN); the Social Phobia and Anxiety Inventory (SPAI); the State-Trait Anxiety Inventory (STAI); Response to Stress Questionnaire, Cancer Version (RSQ-CV); the Functional Assessment of Cancer Therapy (FACT-HNC (head neck cancer) or LC); the Voice Handicap Index (VHI); and the Body Image Scale (BIS).
Cancer treatment and medical history information are gathered from patients' medical records.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 21 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Level of social anxiety and avoidance in HNC patients post-treatment
时间窗: at study entry, day 1
Measured by the Liebowitz Social Anxiety Scale and the Social Phobia and Anxiety Inventory, containing 24 items with each item separately rated for fear as 0 (none), 1 (mild), 2 (moderate) to 3 (severe)and for avoidance behavior as 0 (never), 1 (occasionally), 2 (often), to 3 (usually). Scores are summed with lower values indicating lower levels of social anxiety and avoidance.
次要结局
- Relationship between pre-cancer psychiatric diagnosis and post-treatment social anxiety and avoidance(at study entry)
- Quality of Life(at study entry, day 1)
- Comparison of social anxiety and avoidance in patients with head and neck cancer to patients with lung cancer(at study entry, day 1)
研究者
Kirsten Haman, PhD
Research Assistant Professor; Psychologist
Vanderbilt-Ingram Cancer Center